Everhart B - Search Results

1

New graduates in the burn unit.

Everhart B, Slate M. Everhart B, et al. Crit Care Nurs Clin North Am. 2004 Mar;16(1):51-9. doi: 10.1016/j.ccell.2003.09.006. Crit Care Nurs Clin North Am. 2004. PMID: 15062413 Review.

2

Meeting the needs of graduate nurses in critical care orientation: staged orientation program in surgical intensive care.

Chesnutt BM, Everhart B. Chesnutt BM, et al. Among authors: everhart b. Crit Care Nurse. 2007 Jun;27(3):36-40, 42-51; quiz 52. Crit Care Nurse. 2007. PMID: 17522191 No abstract available.

3

Management of type 2 diabetes.

Seggelke S, Everhart B. Seggelke S, et al. Among authors: everhart b. Nurse Pract. 2013 Jun 10;38(6):13-6. doi: 10.1097/01.NPR.0000430282.47467.5a. Nurse Pract. 2013. PMID: 23695708 Review. No abstract available.

4

Enhanced charge separation in TiO₂/nanocarbon hybrid photocatalysts through coupling with short carbon nanotubes.

Al Mayyahi A, Everhart BM, Shrestha TB, Back TC, Amama PB. Al Mayyahi A, et al. Among authors: everhart bm. RSC Adv. 2021 Mar 22;11(19):11702-11713. doi: 10.1039/d1ra00045d. eCollection 2021 Mar 16. RSC Adv. 2021. PMID: 35423612 Free PMC article.

5

Effectiveness of a Novel ω-3 Krill Oil Agent in Patients With Severe Hypertriglyceridemia: A Randomized Clinical Trial.

Mozaffarian D, Maki KC, Bays HE, Aguilera F, Gould G, Hegele RA, Moriarty PM, Robinson JG, Shi P, Tur JF, Lapointe JF, Aziz S, Lemieux P; TRILOGY (Study of CaPre in Lowering Very High Triglycerides) investigators. Mozaffarian D, et al. JAMA Netw Open. 2022 Jan 4;5(1):e2141898. doi: 10.1001/jamanetworkopen.2021.41898. JAMA Netw Open. 2022. PMID: 34989797 Free PMC article. Clinical Trial.

6

Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.

Verma S, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Dhingra NK, Ketchum SB, Juliano RA, Jiao L, Doyle RT Jr, Granowitz C, Gibson CM, Pinto D, Giugliano RP, Budoff MJ, Mason RP, Tardif JC, Ballantyne CM; REDUCE-IT Investigators. Verma S, et al. Circulation. 2021 Dec 7;144(23):1845-1855. doi: 10.1161/CIRCULATIONAHA.121.056290. Epub 2021 Oct 28. Circulation. 2021. PMID: 34710343 Free article. Clinical Trial.

7

Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.

Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD, Lam CSP, Khurmi NS, Heenan L, Del Prato S, Dyal L, Branch K; AMPLITUDE-O Trial Investigators. Gerstein HC, et al. N Engl J Med. 2021 Sep 2;385(10):896-907. doi: 10.1056/NEJMoa2108269. Epub 2021 Jun 28. N Engl J Med. 2021. PMID: 34215025 Clinical Trial.

8

Inducing Tumor Suppressive Microenvironments through Genome Edited CD47^-/- Syngeneic Cell Vaccination.

Jayaraman Rukmini S, Bi H, Sen P, Everhart B, Jin S, Ye K. Jayaraman Rukmini S, et al. Among authors: everhart b. Sci Rep. 2019 Dec 27;9(1):20057. doi: 10.1038/s41598-019-56370-6. Sci Rep. 2019. PMID: 31882679 Free PMC article.

9

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, Jeppesen OK, Lingvay I, Mosenzon O, Pedersen SD, Tack CJ, Thomsen M, Vilsbøll T, Warren ML, Bain SC; PIONEER 6 Investigators. Husain M, et al. N Engl J Med. 2019 Aug 29;381(9):841-851. doi: 10.1056/NEJMoa1901118. Epub 2019 Jun 11. N Engl J Med. 2019. PMID: 31185157 Clinical Trial.

10

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.

Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM; REDUCE-IT Investigators. Bhatt DL, et al. N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10. N Engl J Med. 2019. PMID: 30415628 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results